Clinical Trial

Compare the Effectiveness of nVNS and TENS on Pain and Quality of Life in Patients of Migraine

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Migraine is a genetically influenced complex neurological disorder characterized by episodes of moderate-to-severe headaches, typically unilateral and frequently accompanied by nausea and heightened sensitivity to light and sound. The common type of migraine headaches is migraine without aura. Migraine has an approximate prevalence of 14.7%, making it the third most common disease in the world. This study aims to compare the effectiveness of non-invasive vagus nerve stimulation (nVNS) and non-invasive transcutaneous electrical nerve stimulation (TENS) in managing pain and improving quality of life (QOL) in patients with migraine.
Trial Details
NCT Number NCT07055776
Lead Sponsor Superior University
Conditions Migraine
Enrollment 72 participants
Start Date 2025-03-17
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-09